Teva Pharmaceuticals Competitors and Similar CompaniesClear all
Viatris's competitors and similar companies include WuXi AppTec, Novartis and AstraZeneca.
 Viatris Viatris is a pharmaceutical company that develops and manufactures branded and generic medicines, biosimilar medicines, and over-the-counter products. |  WuXi AppTec WuXi AppTec (无锡药明康德新药开发股份有限公司, formerly known as WuXi PharmaTech) is a company that provides integrated research, development, and manufacturing solutions for drug discovery and production. |  Novartis Novartis is a company that researches, develops, manufactures, and markets healthcare products. |  AstraZeneca AstraZeneca is a biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines. | |
Founding Date | Founding Date 2020 | Founding Date 2000 | Founding Date 1996 | Founding Date 1999 |
Type | Type Public | Type Public | Type Public | Type Public |
Tags | ||||
Locations | Locations Canonsburg, US HQ Carole Park, AU Millers Point, AU Campos Dos Goytacazes, BR São Paulo, BR Sofia, BG Toronto, CA see more | Locations Shanghai, CN HQ Beijing, CN Changzhou, CN Chengdu, CN Nanjing, CN Nantong, CN Shanghai, CN see more | Locations Basel, CH HQ Tirana, AL Buenos Aires, AR Macquarie Park, AU Kundl, AT Unterlangkampfen, AT Wien, AT see more | Locations Cambridge, GB HQ Alger, DZ Buenos Aires, AR Macquarie Park, AU Macquarie Park, AU North Ryde, AU Wien, AT see more |
Employees | Employees 38,0003% increase | Employees 39,414 | Employees 75,883 | Employees 94,300 |
Valuation ($) | Valuation ($) 14 b | Valuation ($) 20.7 b | Valuation ($) N/A | Valuation ($) 2.7 b |
Financial | ||||
Revenue (est.) | Revenue (est.) $14.3b (FY, 2025) | Revenue (est.) ¥43.1b (FY, 2025) | Revenue (est.) $56.7b (FY, 2025) | Revenue (est.) $58.7b (FY, 2025) |
Cost of goods | Cost of goods $9.3b (FY, 2025) | Cost of goods ¥23.8b (FY, 2025) | Cost of goods $8.4b (FY, 2025) | Cost of goods $4.9b (FY, 2025) |
Gross profit | Gross profit $5b (FY, 2025) | Gross profit ¥21.3b (FY, 2025) | Gross profit $49.8b (FY, 2025) | Gross profit $54.2b (FY, 2025) |
Net income | Net income ($3.5b) (FY, 2025) | Net income ¥19.3b (FY, 2025) | Net income $14b (FY, 2025) | Net income $10.2b (FY, 2025) |
Operating ⚠ | ||||
Countries | Countries 165 (Q1, 2023) | Countries N/A | Countries N/A | Countries 130 (FY, 2021) |
Molecules | Molecules 1.4 k (Q1, 2023) | Molecules 2.8 k (H1, 2023) | Molecules N/A | Molecules N/A |
Funding | ||||
Total funding raised | Total funding raised N/A | Total funding raised $ 902.6m | Total funding raised $ 6.5m | Total funding raised $ 1b |
For sources of this data, please see the company profile
View Company Profiles
WuXi AppTec
HQ
Shanghai, CN
Employees
39,414
WuXi AppTec (无锡药明康德新药开发股份有限公司, formerly known as WuXi PharmaTech) is a company that provides integrated research, development, and manufacturing solutions for drug discovery and production.
View companyNovartis
HQ
Basel, CH
Employees
75,883
Novartis is a company that researches, develops, manufactures, and markets healthcare products.
View companyAstraZeneca
HQ
Cambridge, GB
Employees
94,300
AstraZeneca is a biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines.
View company